AG200-15 (Twirla®), our lead product candidate, is an investigational once-a-week hormonal contraceptive patch. It contains levonorgestrel and ethinyl estradiol. These ingredients have a well-understood efficacy and safety profile in oral contraceptives.
AG200-15 is designed with our proprietary Skinfusion® technology to deliver both hormones over a seven-day period. The patch is applied once weekly for three weeks, followed by a week without a patch. The once-weekly application may be more convenient than a daily option for some women.